Zhuhai Trinomab Pharmaceutical Co (SHSE:688806) Inventories, Raw Materials & Components: ¥20.44 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Zhuhai Trinomab Pharmaceutical Co Inventories, Raw Materials & Components?

Zhuhai Trinomab Pharmaceutical Co SHSE:688806 +7.18% Inventories, Raw Materials & Components is ¥20.44 Mil as of Mar. 2026.

Zhuhai Trinomab Pharmaceutical Co's inventories, raw materials & components for the quarter that ended in Mar. 2026 was ¥20.44 Mil.

Zhuhai Trinomab Pharmaceutical Co's quarterly raw materials declined from Mar. 2025 (¥27.72 Mil) to Dec. 2025 (¥18.44 Mil) but then increased from Dec. 2025 (¥18.44 Mil) to Mar. 2026 (¥20.44 Mil).

Zhuhai Trinomab Pharmaceutical Co's annual raw materials increased from Dec. 2023 (¥25.08 Mil) to Dec. 2024 (¥29.50 Mil) but then declined from Dec. 2024 (¥29.50 Mil) to Dec. 2025 (¥18.44 Mil).

Zhuhai Trinomab Pharmaceutical Co Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Zhuhai Trinomab Pharmaceutical Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhuhai Trinomab Pharmaceutical Co Inventories, Raw Materials & Components Chart

Zhuhai Trinomab Pharmaceutical Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
23.18 25.08 29.50 18.44

Zhuhai Trinomab Pharmaceutical Co Quarterly Data
Dec22 Dec23 Dec24 Mar25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial 25.08 29.50 27.72 18.44 20.44

Zhuhai Trinomab Pharmaceutical Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of ¥20.44 Mil mean?
Zhuhai Trinomab Pharmaceutical Co (SHSE:688806) has a Inventories, Raw Materials & Components of ¥20.44 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Zhuhai Trinomab Pharmaceutical Co and its competitors.
Is Zhuhai Trinomab Pharmaceutical Co's Inventories, Raw Materials & Components too high?
Zhuhai Trinomab Pharmaceutical Co's current Inventories, Raw Materials & Components is ¥20.44 Mil.
How does Zhuhai Trinomab Pharmaceutical Co's Inventories, Raw Materials & Components compare to ZTS?
Zhuhai Trinomab Pharmaceutical Co's Inventories, Raw Materials & Components of ¥20.44 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Zhuhai Trinomab Pharmaceutical Co and its competitors. Zhuhai Trinomab Pharmaceutical Co's current Inventories, Raw Materials & Components is ¥20.44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhuhai Trinomab Pharmaceutical Co stock overvalued right now?
Zhuhai Trinomab Pharmaceutical Co (SHSE:688806) has a current Inventories, Raw Materials & Components of ¥20.44 Mil. The current Inventories, Raw Materials & Components is ¥20.44 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Zhuhai Trinomab Pharmaceutical Co (SHSE:688806), the current Inventories, Raw Materials & Components is ¥20.44 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.